The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages

Reviews in Medical Virology

Volumn 13, Issue 1, 2003, Pages 39-56

  Kedzierska, Katherine ^b   Crowe, Suzanne M ^b   Turville, Stuart ^b   Cunningham, Anthony L ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COLONY STIMULATING FACTOR 1; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE ACTIVATING FACTOR;

BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL STIMULATION; CELL TRANSPORT; DENDRITIC CELL; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONOCYTE; PROTEIN EXPRESSION; REVIEW; VIROGENESIS; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

CHEMOKINES; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; MONOCYTES; RECEPTORS, CHEMOKINE; VIRUS REPLICATION;

EID: 0037238708     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.369     Document Type: Review

References (176)

1. Alkhatib G, Combadiere C, Broder et al. CC CKR5; a RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage tropic HIV-1. Science 1996; 272: 1955-1958.
2. Dragic T, Litwin V, Allaway G, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-673.
3. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor; functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 1996; 272: 872-877.
4. Collman R, Hassan NF, Walker R, et al. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocytetropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J Exp Med 1989; 170: 1149-1163.
5. Gartner S, Popovic M. Macrophage tropism of HIV-1. AIDS Res Human Retrovirus 1990; 6: 1017-1021.
6. Fenyo EM, Alber J, Asjo B. Replicative capacity, cytopathic effect and cell tropism of HIV. AIDS 1989; 3: S5-S12.
7. Schuitemaker H, Kootstra NA, de Goede RE, et al. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T cell line tropism and syncytium inducing ability in primary T cell culture. J Virol 1991; 65: 356-363.
8. Yi Y, Rana S, Turner JD, Gaddis N, Collman RG. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 1998; 72: 772-777.
9. Simmons G, Reeves JD, McKnight A, et al. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 1998; 72: 8453-8457.
10. Verani A, Pesenti E, Polo S, et al. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J Immunol 1998; 161: 2084-2088.
11. Yi Y, Isaacs SN, Williams DA, et al. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. J Virol 1999; 73: 7117-7125.
12. Connor R, Mohri H, Cao Y, Ho D. Increased viral burden and cytopathicity correlate temporally with CD4+ T lymphocyte decline and clinical progression in human immunodeficiency virus type-1 infected individuals. J Virol 1993; 67: 1772-1777.
13. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85: 1149-1158.
14. van't Wout AB, Koostra NA, Mulder-Kampinga GA, et al. Macrophage tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994; 94: 2060-2067.
15. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterisation of HIV-1 patients with primary infection. Science 1993; 261: 1179-1181.
16. Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000; 74: 6087-6095.
17. Spira AI, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996; 183: 215-225.
18. Crowe SM. Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection. Aust N Z J Med 1995; 25: 777-783.
19. Sonza S, Maerz A, Deacon N, et al. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 1996; 70: 3863-3869.
20. Crowe SM, Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J Leukoc Biol 2000; 68: 345-350.
21. Cimarelli A, Zambruno G, Marconi A, et al. Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr 1994; 7: 230-235.
22. Kawamura T, Cohen SS, Borris DL, et al. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med 2000; 192: 1491-1500.
23. Reece JC, Handley AJ, Anstee EJ, et al. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J Exp Med 1998; 187: 1623-1631.
24. Bakri Y, Schiffer C, Zennou V, et al. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J Immunol 2001; 166: 3780-3788.
25. Cameron PU, Freudenthal PS, Barker JM, et al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 1992; 257: 383-387.
26. Pope M, Gezelter S, Gallo N, Hoffman L, Steinman RM. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J Exp Med 1995; 182: 2045-2056.
27. Masurier C, Salomon B, Guettari N, et al. Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol 1998; 72: 7822-7829.
28. Pope M, Betjes MG, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994; 78: 389-398.
29. Curtis BM, Scharnowske S, Watson AJ. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci USA 1992; 89: 8356-8360.
30. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100: 587-597.
31. Turville SG, Arthos J, Donald KM, et al. HIV gp120 receptors on human dendritic cells. Blood 2001; 98: 2482-2488.
32. Turville SG, Cameron PU, Arthos J, et al. Bitter-sweet symphony: defining the role of dendritic cell gp120 receptors in HIV infection. J Clin Virol 2001; 22: 229-239.
33. Lee B, Leslie G, Soilleux E, et al. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 2001; 75: 12028-12038.
34. Choe H, Farzan M, Sun Y, et al. The beta chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135-1148.
35. Li S, Juarez J, Alali M, et al. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J Virol 1999; 73: 9741-9755.
36. Lewin SR, Sonza S, Irving LB, et al. Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages. AIDS Res Hum Retroviruses 1996; 12: 877-883.
37. Kozak SL, Platt EJ, Madani N, et al. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol 1997; 71: 873-882.
38. Naif HM, Li S, Alali M, et al. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 1998; 72: 830-836.
39. Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 1998; 72: 4962-4969.
40. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage-tropic isolates of human immunodeficiency virus type 1. J Virol 1998; 72: 2855-2864.
41. Schuitemaker H, Kootstra N, Koppelman M, et al. Proliferation-dependent HlV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 1992; 89: 1154-1160.
42. McElrath MJ, Pruett JE, Cohn ZA. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci 1989; 86: 675-679.
43. Lewin SR, Kirihara J, Sonza S, et al. HIV-1 DNA and mRNA concentrations are similar to peripheral blood monocytes and alveolar macrophages in HIV-1 infected individuals. AIDS 1998; 12: 719-727.
44. Kedzierska K, Maerz A, Warby T, et al. Granulocytemacrophage colony stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages. AIDS 2000; 14: 1739-1748.
45. Di Marzio P, Tse J, Landau N. Chemokine receptor regulation and HIV type 1 tropism in monocytemacrophages. AIDS Res Hum Retroviruses 1998; 14: 129-138.
46. Fear W, Kesson A, Naif H, Lynch G, Cunningham A. Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol 1998; 72: 1334-1344.
47. Combadiere C, Ahuja SK, Van Damme J, et al. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 1995; 270: 29671-29675.
48. Crowe SM, Mills J, McGrath MS. Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses 1987; 3: 135-145.
49. Kazazi F, Mathijs JM, Chang J, et al. Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol 1992; 73: 941-949.
50. Collman R, Godfrey B, Cutilli J, et al. Macrophage tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol 1990; 64: 4468-4476.
51. Sonza S, Maerz A, Uren S, et al. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression. AIDS Res Hum Retroviruses 1995; 11: 769-776.
52. Sica A, Saccani A, Borsatti A, et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 1997; 185: 969-974.
53. Rich EA, Chen ISY, Zack JA, Leonard ML, O'Brien WA. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 1992; 89: 176-183.
54. Olafsson K, Smith MS, Marshburn P, Carter SG, Haskill S. Variation of HIV infectibility of macrophages as a function of donor, stage of differentiation, and site of origin. J Acquir Immune Defic Syndr 1991; 4: 154-164.
55. Kesson AM, Fear WR, Kazazi F, et al. Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. J Infect Dis 1993; 168: 571-579.
56. Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J Virol 1991; 65: 736-742.
57. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362: 359-362.
58. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997; 276: 1857-1861.
59. He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997; 385: 645-649.
60. Albright AV, Shieh JT, Itoh T, et al. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 1999; 73: 205-213.
61. Lavi E, Strizki JM, Ulrich AM, et al. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol 1997; 151: 1035-1042.
62. Park IW, Koziel H, Hatch W, et al. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Am J Respir Cell Mol Biol 1999; 20: 864-871.
63. Worgall S, Connor R, Kaner RJ, et al. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages. J Virol 1999; 73: 5865-5874.
64. Cunningham AL, Li S, Juarez J, et al. The level of HIV infection of macrophages is determined by interaction of viral and host cell genotypes. J Leukoc Biol 2000; 68: 311-317.
65. Soilleux EJ, Morris LS, Leslie G, et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002; 71: 445-457.
66. Saphire AC, Bobardt MD, Zhang Z, David G, Gallay PA. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol 2001; 75: 9187-9200.
67. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245-3287.
68. Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci USA 1999; 96: 5215-5220.
69. Patterson S, Rae A, Hockey N, Gilmour J, Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol 2001; 75: 6710-6713.
70. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, et al. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 2000; 1: 353-357.
71. a. Turville SG, Cameron PN, Handley A, Lin G, Pohlman S, Doms RW, Cunningham AL. Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunol 2002; 3: 975-983.
72. Donaghy H, Pozniak A, Gazzard B, et al. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001; 98: 2574-2576.
73. Pacanowski J, Kahi S, Baillet M, et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 2001; 98: 3016-3021.
74. Feldman S, Stein D, Amrute S, et al. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin Immunol 2001; 101: 201-210.
75. Granelli-Piperno A, Moser B, Pope M, et al. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med 1996; 184: 2433-2438.
76. Zaitseva M, Blauvelt A, Lee S, et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat Med 1997; 3: 1369-1375.
77. Delgado E, Finkel V, Baggiolini M, et al. Mature dendritic cells respond to SDF-1, but not to several beta-chemokines. Immunobiology 1998; 198: 490-500.
78. Granelli-Piperno A, Delgado E, Finkel V, Paxton W, Steinman RM. Immature dendritic cells selectively replicate macrophage tropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J Virol 1998; 72: 2733-2737.
79. Rubbert A, Combadiere C, Ostrowski M, et al. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol 1998; 160: 3933-3941.
80. Rappersberger K, Gartner S, Schenk P, et al. Langerhans cells are an actual site of HIV-1 replication. Intervirology 1988; 29: 185-194.
81. Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575-585.
82. Hausser GA, Hultgren C, Akagawa K, Tsunetsugu-Yokota Y, Meyerhans A. Infection of cultured immature dendritic cells with human immunodeficiency virus type 1. Adv Exp Med Biol 1995; 378: 477-479.
83. Grassi F, Dezutter-Dambuyant C, McIlroy D, et al. Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol 1998; 64: 484-493.
84. Blauvelt A, Asada H, Saville MW, et al. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J Clin Invest 1997; 100: 2043-2053.
85. Broder CC, Berger EA. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages. Proc Natl Acad Sci USA 1995; 92: 9004-9008.
86. Sattentau QJ. HIV gp120: double lock strategy foils host defences. Structure 1998; 6: 945-949.
87. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991; 253: 71-74.
88. Cocchi F, DeVico AL, Garzino-Demo A, et al. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 1996; 2: 1244-1247.
89. Cooley LA, Lewin SR. HIV-1 cell entry and advances in viral entry inhibitor therapy. J Clin Virol 2002; in press.
90. Collman RG, Yi Y. Cofactors for human immunodeficiency virus entry into primary macrophages. J Infect Dis 1999; 179: S422-S426.
91. Samson M, Libert F, Doranz B, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996; 382: 722-725.
92. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862.
93. Chang J, Naif HM, Li S, et al. Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro. J Virol 1996; 70: 7792-7803.
94. Naif HM, Li S, Alali M, et al. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J Virol 1999; 73: 4866-4881.
95. Lewin SR, Lambert P, Deacon NJ, Mills J, Crowe SM. Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages. J Virol 1997; 71: 2114-2119.
96. Cameron PU, Lowe MG, Sotzik F, et al. The interaction of macrophage and non macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J Exp Med 1996; 183: 1851-1856.
97. Collman RG, Yi Y, Liu QH, Freedman BD. Chemokine signaling and HIV-1 fusion mediated by macrophage CXCR4: implications for target cell tropism. J Leukoc Biol 2000; 68: 318-323.
98. Naif HM, Cunningham AL, Alali M, et al. A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4. J Virol 2002; 76: 3114-3124.
99. Liu QH, Williams DA, McManus C, et al. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc Natl Acad Sci USA 2000; 97: 4832-4837.
100. Lathey JL, Brambilla D, Goodenow MM, et al. Coreceptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient? J Leukoc Biol 2000; 68: 324-330.
101. Collman R, Balliet JW, Gregory SA, et al. An infectious molecular clone of an unusual macrophage tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 1992; 66: 7517-7521.
102. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J Exp Med 1989; 169: 1137-1151.
103. Kalter DC, Nakamura M, Turpin JA, et al. Enhanced HIV replication in macrophage colony stimulating factor treated monocytes. J Immunol 1991; 146: 298-306.
104. Wang J, Roderiquez G, Oravecz T, Norcross MA. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 1998; 72: 7642-7647.
105. Matsuda S, Akagawa K, Honda M, et al. Suppression of HIV replication in human monocyte derived macrophages induced by granulocyte macrophage colony stimulating factor. AIDS Res Hum Retroviruses 1995; 11: 1031-1038.
106. Kutza J, Crim L, Feldman S, et al. Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages. J Immunol 2000; 164: 4955-4960.
107. Armitage R. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 1994; 6: 407-413.
108. Griffin G, Leung K, Folks T, Kunkel S, Nabel G. Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression. Res Virol 1991; 142: 233-238.
109. Naif H, Ho-Shon M, Chang J, Cunningham AL. Molecular mechanisms of IL-4 effect on HIV expression in promonocytic cell lines and primary human monocytes. J Leukoc Biol 1994; 56: 335-339.
110. Herbein G, Gordon S. 55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 1997; 71: 4150-4156.
111. Han X, Becker K, Degen H, Jablonowski H, Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur J Clin Invest 1996; 26: 286-292.
112. Esser R, von Briesen H, Brugger M, et al. Secretory repertoire of HIV-infected human monocytes/macrophages. Pathobiology 1991; 59: 219-222.
113. Esser R, Glienke W, von Briesen H, Rubsamen-Waigmann H, Andreesen R. Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 1996; 88: 3474-3481.
114. Esser R, Glienke W, Andreesen R, et al. Individual cell analysis of the cytokine repertoire in human immunodeficiency virus-1-infected monocytes/macrophages by a combination of immunocytochemistry and in situ hybridization. Blood 1998; 91: 4752-4760.
115. Dinarello C. Interleukin-1. Cytokine Growth Factor Rev 1997; 8: 253-265.
116. Poli G, Kinter A, Fauci A. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1994; 91: 108-112.
117. Kinter A, Poli G, Fox L, Hardy E, Fauci A. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 1995; 154: 2448-2459.
118. Granowitz E, Saget B, Wang M, Dinarello C, Skolnik P. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol Med 1995; 1: 667-677.
119. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell R. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 1997; 185: 461-469.
120. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990; 172: 151-158.
121. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992; 8: 191-197.
122. Fan SX, Turpin JA, Aronovitz JR, Meltzer MS. Interferon-gamma protects primary monocytes against infection with human immunodeficiency virus type 1. J Leukoc Biol 1994; 56: 362-368.
123. Denis M, Ghadirian E. Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994; 10: 795-802.
124. Dhawan S, Heredia A, Wahl LM, et al. Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes. Pathobiology 1995; 63: 93-99.
125. Shirazi Y, Pitha PM. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J Virol 1992; 66: 1321-1328.
126. Poli G, Biswas P, Fauci AS. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res 1994; 24: 221-233.
127. Baca-Regen L, Heinzinger N, Stevenson M, Gendelman HE. Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J Virol 1994; 68: 7559-7565.
128. Gessani S, Puddu P, Varano B, et al. Role of endogenous interferon-beta in the restriction of HIV replication in human monocyte/macrophages. J Leukoc Biol 1994; 56: 358-361.
129. Le Page C, Genin P, Baines M, Hiscott J. Interferon activation and innate immunity. Rev Immunogenet 2000; 2: 374-386.
130. Koyanagi Y, O'Brien WA, Zhao JQ, et al. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988; 241: 1673-1675.
131. Hariharan D, Douglas SD, Lee B, et al. Interferon-gamma upregulates CCR5 expression in cord and adult blood mononuclear phagocytes. Blood 1999; 93: 1137-1144.
132. Bovolenta C, Lorini AL, Mantelli B, et al. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. J Immunol 1999; 162: 323-330.
133. Biswas P, Poli G, Kinter AL, et al. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J Exp Med 1992; 176: 739-750.
134. Han X, Becker K, Degen HJ, Jablonowski H, Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur J Clin Invest 1996; 26: 286-292.
135. Armitage J. Emerging applications of recombinant human granulocyte-macrophage colony stimulating factor. Blood 1998; 92: 4491-4508.
136. Perno CF, Yarchoan R, Cooney DA, et al. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 1989; 169: 933-951.
137. Schuitemaker H, Kootstra NA, van Oers MH, et al. Induction of monocyte proliferation and HIV expression by IL-3 does not interfere with anti-viral activity of zidovudine. Blood 1990; 76: 1490-1493.
138. Perno CF, Cooney DA, Gao WY, et al. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood 1992; 80: 995-1003.
139. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238: 800-802.
140. Pomerantz RJ, Feinberg MB, Trono D, Baltimore D. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J Exp Med 1990; 172: 253-261.
141. Hammer SM, Gillis JM, Pinkston P, Rose RM. Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages. Blood 1990; 75: 1215-1219.
142. Di Marzio P, Tse J, Landau NR. Chemokine receptor regulation and HIV type 1 tropism in monocytemacrophages. AIDS Res Hum Retroviruses 1998; 14: 129-138.
143. Lopez A, Shannon M, Hercus T, et al. Residue 21 of human granulocyte macrophage colony stimulating factor is critical for biological activity and for high but not low affinity binding. EMBO J 1992; 11: 909-916.
144. Crowe SM, Lopez A. GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineage. J Leukoc Biol 1997; 62: 41-48.
145. Kedzierska K, Rainbird M, Lopez A, Crowe S. Effect of GM-CSF on HIV-1 replication in monocytes/macrophages in vivo and in vitro: a review. Vet Immunol Immunopathol 1998; 63: 111-121.
146. Kedzierska K, Mak J, Mijch A, et al. Granulocytemacrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J Infect Dis 2000; 181: 390-394.
147. Moore K, de Waal Malefyt R, Coffman R, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
148. Weissman D, Poli G, Fauci AS. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res Hum Retroviruses 1994; 10: 1199-1206.
149. Weissman D, Poli G, Fauci AS. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 442-449.
150. Montaner LJ, Griffin P, Gordon S. Interleukin 10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood derived human macrophages in vitro. J Gen Virol 1994; 75: 3393-3400.
151. Naif HM, Chang J, Ho-Shon M, Li S, Cunningham AL. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression. AIDS Res Hum Retroviruses 1996; 12: 1237-1245.
152. de Vries J. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998; 102: 165-169.
153. Montaner LJ, Doyle AG, Collin M, et al. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med 1993; 178: 743-747.
154. Montaner LJ, Bailer RT, Gordon S. IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity. J Leukoc Biol 1997; 62: 126-132.
155. Bailer RT, Lee B, Montaner LJ. IL-13 and TNF-alpha inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression. Eur J Immunol 2000; 30: 1340-1349.
156. Naif HM, Li S, Ho-Shon M, et al. The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication. J Immunol 1997; 158: 501-511.
157. Krakauer T, Vilcek J, Oppenheim J. Proinflammatory cytokines. In Fundamental Immunology, Paul W (ed.). Lippincott-Raven: Philadelphia, 1998; 775-811.
158. Maciaszek JW, Parada NA, Cruikshank WW, et al. IL-16 represses HIV-1 promoter activity. J Immunol 1997; 158: 5-8.
159. Truong MJ, Darcissac EC, Hermann E, et al. Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells. J Virol 1999; 73: 7008-7013.
160. Rollins B. Chemokines. Blood 1997; 90: 909-928.
161. Cocchi F, DeVico A, Garzino-Demo A, et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-1815.
162. Coffey M, Woffendin C, Phare S, Strieter R, Markovitz D. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am J Physiol 1997; 272: 1025-1029.
163. Kelly MD, Naif HM, Adams SL, Cunningham AL, Lloyd AR. Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol 1998; 160: 3091-3095.
164. Kitai R, Zhao M, Zhang N, Hua L, Lee S. Role of MIP-lbeta and RANTES
165. Paxton W, Martin S, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996; 2: 412-417.
166. Jiang Y, Jolly P. Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages. J Hum Virol 1999; 2: 123-132.
167. Paul W. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77: 1859-1870.
168. Foli A, Saville M, Baseler M, Yarchoan R. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 1995; 85: 2114-2123.
169. Singh A, Collman RG. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies. J Virol 2000; 74: 10229-10235.
170. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 2001; 12: 133-145.
171. Clerici M, Shearer G. A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-111.
172. Rizzardi G, Marriott J, Cookson S, et al. Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2- type response. Clin Exp Immunol 1998; 114: 61-65.
173. Cunningham AL, Naif H, Saksena N, et al. HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype. J Leukoc Biol 1997; 62: 117-125.
174. Wahl SM, Greenwell-Wild T, Hale-Donze H, Moutsopoulos N, Orenstein JM. Permissive factors for HIV-1 infection of macrophages. J Leukoc Biol 2000; 68: 303-310.
175. Norak RM, Holzer TJ, Kennedy MM, Heynen CA, Dawson G. The effect of interleukin-4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-1. AIDS Res Hum Retrovir 1990; 6: 973-976.
176. Vyaka A, McKeating J, Meager A, Beverly P. Tumur necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 1990; 4: 21-27.